Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis

NCT04999839 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

259

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Plaque Psoriasis

Interventions

DRUG: NDI-034858 study drug
DRUG: NDI-034858 study drug
DRUG: NDI-034858 study drug
DRUG: NDI-034858 study drug
OTHER: Placebo

Sponsor

Takeda

Collaborators

[object Object]
[object Object]